azacitidine and Chronic Kidney Diseases

azacitidine has been researched along with Chronic Kidney Diseases in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
An, XF; Chen, C; Chen, MM; Jiang, H; Liu, HL; Si, ZL; Su, K; Tan, NH; Vaziri, ND; Wang, LX; Wu, WH; Zhang, ZH; Zhou, W1
Fan, X; Huang, T; Lang, Y; Li, X; Lv, Z; Sheng, Q; Wang, Q; Wang, R; Zhang, T; Zhao, Y; Zhen, J; Zhou, P1
Adès, L; Angeli, E; Bally, C; Calleja, A; Chevallier, P; Cluzeau, T; Fenaux, P; Garnier, A; Guillaume, T; Jullien, M; Le Bourgeois, A; Le Gouill, S; Ngo Nloga, AM; Peterlin, P1
Chang, FC; Chang, YT; Chen, YM; Chiang, WC; Chou, YH; Chu, TS; Hsu, HL; Lai, CF; Lin, CH; Lin, SL; Pan, SY; Tsai, MH; Wu, MS; Yang, CC1
Allison, SJ1

Other Studies

5 other study(ies) available for azacitidine and Chronic Kidney Diseases

ArticleYear
Dihydroartemisinin suppresses renal fibrosis in mice by inhibiting DNA-methyltransferase 1 and increasing Klotho.
    Acta pharmacologica Sinica, 2022, Volume: 43, Issue:10

    Topics: Adenine; Animals; Artemisinins; Azacitidine; beta Catenin; Biotin; DNA; DNA Modification Methylases; Fibrosis; Glucuronidase; HEK293 Cells; Humans; Kidney; Klotho Proteins; Mice; Proteasome Endopeptidase Complex; Renal Insufficiency, Chronic; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ubiquitins; Ureteral Obstruction

2022
ROS promote hyper-methylation of NDRG2 promoters in a DNMTS-dependent manner: Contributes to the progression of renal fibrosis.
    Redox biology, 2023, Volume: 62

    Topics: Animals; Azacitidine; DNA Methylation; DNA, A-Form; Epigenesis, Genetic; Fibrosis; Methyltransferases; Mice; Reactive Oxygen Species; Renal Insufficiency, Chronic

2023
Azacitidine in patients older than 80 years with acute myeloid leukaemia or myelodysplastic syndromes: a report on 115 patients.
    British journal of haematology, 2020, Volume: 190, Issue:3

    Topics: Abnormal Karyotype; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Bone Marrow Diseases; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Febrile Neutropenia; Female; France; Hospitalization; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Multicenter Studies as Topic; Myelodysplastic Syndromes; Renal Insufficiency, Chronic; Retrospective Studies; Treatment Outcome

2020
DNA methyltransferase inhibition restores erythropoietin production in fibrotic murine kidneys.
    The Journal of clinical investigation, 2016, Volume: 126, Issue:2

    Topics: Animals; Azacitidine; Basic Helix-Loop-Helix Transcription Factors; Collagen Type I; Collagen Type I, alpha 1 Chain; DNA Modification Methylases; Erythropoietin; Fibrosis; Mice; Mice, Transgenic; Myofibroblasts; Pericytes; Receptor, Platelet-Derived Growth Factor beta; Renal Insufficiency, Chronic

2016
Anaemia: Targeting epigenetics in renal anaemia.
    Nature reviews. Nephrology, 2016, Volume: 12, Issue:3

    Topics: Animals; Azacitidine; DNA Modification Methylases; Erythropoietin; Myofibroblasts; Pericytes; Renal Insufficiency, Chronic

2016